According to the latest report by IMARC Group, titled “Urology Robotic Surgery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the global urology robotic surgery market size reached US$ 1.6 Billion in 2022. Urology robotic surgery, also known as robot-assisted urologic surgery, is a specialized surgical technique that utilizes robotic systems to assist urologists in performing various urological procedures. It combines the precision and dexterity of robotic technology with the skills of the surgeon to enhance surgical outcomes and minimize invasiveness. The robotic arms mimic the surgeon's hand movements, allowing for greater precision, range of motion, and maneuverability during the procedure. It offers various benefits such as smaller incisions, reduced blood loss, decreased postoperative pain, shorter hospital stays, and faster recovery compared to traditional open surgery.
Global Urology Robotic Surgery Market Trends:
The urology robotic surgery market is driven by the increasing prevalence of urinary tract diseases and urological conditions such as prostate cancer, kidney disorders, and bladder diseases. Urology robotic surgery offers several advantages over traditional open surgery, including reduced invasiveness, shorter hospital stays, faster recovery, and improved surgical precision. Besides, the rising geriatric population that is more susceptible to such diseases represent another major growth-inducing factor. Additionally, advancements in robotic technology, such as improved instrumentation, enhanced imaging capabilities, and intuitive control systems, are further propelling market growth. Moreover, the integration of robot-assisted flexible endoscopes with the system to access and treat complex anatomies and enhance precision in diagnostic proceedings is also influencing the market growth. Furthermore, the expanding base of skilled robotic surgeons, increasing research and development (R&D) activities to manufacture urology surgical robots with enhanced efficacy and the rising investments in healthcare infrastructure are also playing a significant role in driving the urology robotic surgery market. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 10.5% during 2023-2028.
- Based on the component, the market has been segmented into robotic surgery systems, instruments and accessories and services. According to the report, instruments and accessories represented the leading segment.
- On the basis of the application, the market has been categorized into robotic prostatectomy, robotic cystectomy, robotic pyeloplasty, robotic nephrectomy and others. According to the report, robotic prostatectomy accounted for the largest market share.
- Region-wise, the market has been segmented into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa.
- The competitive landscape of the market has also been examined, with some of the key players being Intuitive Surgical Inc., Johnson & Johnson, Medtronic plc, Stryker Corporation, and Surgical Science Sweden AB.
|Base Year of the Analysis
| Historical Period
||Component, Application, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Intuitive Surgical Inc., Johnson & Johnson, Medtronic plc, Stryker Corporation, Surgical Science Sweden AB, etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800